Duke University Medical Center, Duke Cancer Center — Durham, North Carolina

Duke University Medical Center, Duke Cancer Center is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Duke University Medical Center, Duke Cancer Center has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Colorectal Carcinoma, Gastric Adenocarcinoma, GEJ Adenocarcinoma.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer, Endocyte.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke University Medical Center, Duke Cancer Center?

Duke University Medical Center, Duke Cancer Center has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke University Medical Center, Duke Cancer Center conducted?

Duke University Medical Center, Duke Cancer Center has 5 clinical trials on record, with 3 currently active. Their work covers Colorectal Carcinoma, Gastric Adenocarcinoma, GEJ Adenocarcinoma.

Is Duke University Medical Center, Duke Cancer Center accredited by Crixeo Health?

Yes — Duke University Medical Center, Duke Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Duke University Medical Center, Duke Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.